In contrast to peritumor-derived FABP4, mRNA FABP4 expression is significantly decreased in tumors compared to normal prostate epithelial cell/tissue when examining human prostate cancer cell lines and clinical biopsy samples (Das et al., 2001; Tölle et al., 2011). This evidence concerns the gene FABP4 and prostate cancer.